Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review

A El-Kholy, HA El-Mahallawy… - Infection and drug …, 2021 - Taylor & Francis
Purpose This article is the first to review published reports on the prevalence of multidrug-
resistant (MDR) gram-negative infections in Egypt and gain insights into antimicrobial …

[HTML][HTML] Antibiotic therapy for pan-drug-resistant infections

MA Ozma, A Abbasi, M Asgharzadeh… - Le infezioni in …, 2022 - ncbi.nlm.nih.gov
Antibiotic resistance occurs when microorganisms resist the drugs used against the infection
caused by them and neutralize their effects over time using various mechanisms. These …

[HTML][HTML] Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and …

R Taha, O Kader, S Shawky, S Rezk - Annals of Clinical Microbiology and …, 2023 - Springer
Abstract Background Carbapenemase-producing Enterobacterales (CPE) show rapid global
dissemination and pose a significant therapeutic challenge. This study aimed to characterize …

[HTML][HTML] Synergistic antibacterial activity of silver nanoparticles biosynthesized by carbapenem-resistant Gram-negative bacilli

SH Haji, FA Ali, STH Aka - Scientific Reports, 2022 - nature.com
Nanotechnology is being investigated for its potential to improve nanomedicine for human
health. The purpose of this study was to isolate carbapenemase-producing Gram-negative …

[HTML][HTML] Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and …

W Elmonir, NK Abd El-Aziz, YH Tartor, SM Moustafa… - Biology, 2021 - mdpi.com
Simple Summary Carbapenems and colistin are reserved as the last-resort treatments of
multidrug-resistant (MDR) infections in humans. Consequently, the emergence of …

[HTML][HTML] Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM …

NA Abdelaziz - Antimicrobial Resistance & Infection Control, 2022 - Springer
Abstract Background Carbapenem-resistant Enterobacterales (CRE), currently listed by the
World Health Organization (WHO) as top priority critical pathogens, are a major global …

Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic …

N Wang, M Zhan, J Liu, Y Wang, Y Hou… - Infection and Drug …, 2022 - Taylor & Francis
Purpose In this study, we analyzed the clinical distribution and drug resistance of
carbapenem-resistant Klebsiella pneumoniae (CRKP) strains, the minimum inhibitory …

[HTML][HTML] Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli

SH Haji, STH Aka, FA Ali - PLoS One, 2021 - journals.plos.org
Background Emerging worldwide in the past decade, there has been a significant increase
in multidrug-resistant bacteria from serious nosocomial infections, especially …

Carbapenem use is driving the evolution of imipenemase 1 variants

Z Cheng, CR Bethel, PW Thomas… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
ABSTRACT Metallo-β-lactamases (MBLs) are a growing clinical threat because they
inactivate nearly all β-lactam-containing antibiotics, and there are no clinically available …

[HTML][HTML] Clinical carbapenem-resistant Klebsiella pneumoniae isolates simultaneously harboring bla NDM-1, bla OXA types and qnrS genes from the Kingdom of …

M Shahid, N Ahmad, NK Saeed, M Shadab… - Frontiers in cellular …, 2022 - frontiersin.org
The prevalence of Carbapenem-resistant Klebsiella pneumoniae (CRKP) is currently
increasing worldwide, prompting WHO to classify it as an urgent public health threat. CRKP …